Tumor-Lymph Node Mapping

Part of paid clinical trials in Rochester, New York.

Sponsor
University of Rochester
Study ID
NCT07054944
Status
Recruiting
Apply to this trial

Conditions

  • Germ Cell Tumor
  • Pediatric Solid Tumors
  • Rhabdomyosarcoma
  • Sarcoma

Eligibility Criteria

Sex
ALL
Age
1 Month - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • ICG (Indocyanine Green) — DIAGNOSTIC_TEST
    Lymphatic mapping

Study Details

The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.

Key Dates

Start date
Apr 13, 2026
Status verified
Apr 2026
Primary completion
Jul 30, 2028
Completion
Jul 30, 2028

Study Design

Enrollment
10 participants (estimated)

Arms

  • Arm: Indocyanine Green (ICG) and KARL STORZ ICG Imaging System

Primary Outcome Measure

Percentage of Patients with Successful Sentinel Lymph Node (SLN) Detection Using ICG Fluorescence [ Time Frame: Baseline ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Rochester Medical CenterRochesterNew York14642
Abdelhafeez Abdelhafeez
[email protected]

Find similar trials in Rochester, NY

By research site
University of Rochester Medical Center· Rochester, NY

Related Studies